BOI:EPA
Boiron SA
€19.20
arrow_upward
+0.79%(+0.15) 1D
Nov 13, 5:35:27 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Open
€19.25
High
€19.25
Low
€18.95
Mkt. cap
330.69M
Avg. vol.
4.88K
Volume
1.71K
P/E ratio
12.73
52-wk high
€32.25
52-wk low
€16.90
EPS
€1.51
Shares outstanding
17.55M
No. of employees
3K
Open
€19.25
High
€19.25
Low
€18.95
Mkt. cap
330.69M
Avg. vol.
4.88K
Volume
1.71K
P/E ratio
12.73
52-wk high
€32.25
52-wk low
€16.90
EPS
€1.51
Shares outstanding
17.55M
No. of employees
3K
News stories
From web sources and news partners
TradingKey
·
30 minutes ago
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
TradingView
·
7 hours ago
SpaceX's S&P 500 bid gets new life as Elon Musk pitches Tesla merger
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron SA
CEO-
Employees2.62K
FoundedJun 7, 1932
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteboiron.fr